SOX2 and neoplasm: Thus, Wibertz and coworkers have studied two cohorts of LSQCCs, for a total of 891 patients and have observed that 8% of these patients display a high level of SOX2 amplification, associated with lower tumor grade and a prolonged overall survival [71].